Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,265
archived clinical trials in
Crohns Disease

Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease, and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease
Status: Enrolling
Updated:  5/18/2017
Virginia Commonwealth University
mi
from
Richmond, VA
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease, and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease
Status: Enrolling
Updated: 5/18/2017
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease, and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease
Status: Enrolling
Updated:  5/18/2017
QPharm Pty Limited
mi
from
Herston,
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease, and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease
Status: Enrolling
Updated: 5/18/2017
QPharm Pty Limited
mi
from
Herston,
Click here to add this to my saved trials
Calprotectin-Directed Humira® Maintenance Therapy (CADHUM)
Calprotectin-Directed Humira® Maintenance Therapy, a Double-blind, Double-dummy, Randomized Controlled Trial in Crohn's Disease
Status: Enrolling
Updated:  5/23/2017
University of Michigan Health System
mi
from
Ann Arbor, MI
Calprotectin-Directed Humira® Maintenance Therapy (CADHUM)
Calprotectin-Directed Humira® Maintenance Therapy, a Double-blind, Double-dummy, Randomized Controlled Trial in Crohn's Disease
Status: Enrolling
Updated: 5/23/2017
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Self-Management Assistance for Recommended Treatment (SMART) Portal
Self-Management Assistance for Recommended Treatment (SMART) Portal
Status: Enrolling
Updated:  7/18/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Self-Management Assistance for Recommended Treatment (SMART) Portal
Self-Management Assistance for Recommended Treatment (SMART) Portal
Status: Enrolling
Updated: 7/18/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Self-Management Assistance for Recommended Treatment (SMART) Portal
Self-Management Assistance for Recommended Treatment (SMART) Portal
Status: Enrolling
Updated:  7/18/2017
BeHealth Solutions, LLC
mi
from
Charlottesville, VA
Self-Management Assistance for Recommended Treatment (SMART) Portal
Self-Management Assistance for Recommended Treatment (SMART) Portal
Status: Enrolling
Updated: 7/18/2017
BeHealth Solutions, LLC
mi
from
Charlottesville, VA
Click here to add this to my saved trials
The Role of Small Bowel Ultrasound in Initiation of Infliximab in Crohn's Disease Patients
The Role of Small Bowel Ultrasound After Ileocolic Resection or When Starting Infliximab in Crohn's Disease Patients
Status: Enrolling
Updated:  7/18/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
The Role of Small Bowel Ultrasound in Initiation of Infliximab in Crohn's Disease Patients
The Role of Small Bowel Ultrasound After Ileocolic Resection or When Starting Infliximab in Crohn's Disease Patients
Status: Enrolling
Updated: 7/18/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects
A Single Centre, Single Sequence, Open-Label, Repeat-Dose Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects
Status: Enrolling
Updated:  7/24/2017
GSK Investigational Site
mi
from
Buffalo, NY
A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects
A Single Centre, Single Sequence, Open-Label, Repeat-Dose Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects
Status: Enrolling
Updated: 7/24/2017
GSK Investigational Site
mi
from
Buffalo, NY
Click here to add this to my saved trials
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated:  8/31/2017
Indiana University
mi
from
Indianapolis, IN
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated: 8/31/2017
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated:  8/31/2017
University of Iowa
mi
from
Iowa City, IA
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated: 8/31/2017
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated:  8/31/2017
University of Michigan
mi
from
Ann Arbor, MI
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated: 8/31/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated:  8/31/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated: 8/31/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Alliance Clinical Research
mi
from
Oceanside, CA
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Alliance Clinical Research
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Clinical Research of the Rockies
mi
from
LaFayette, CO
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Clinical Research of the Rockies
mi
from
LaFayette, CO
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Gastroenterology Consultants of Clearwater
mi
from
Clearwater, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Gastroenterology Consultants of Clearwater
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
West Coast Endoscopy Center
mi
from
Clearwater, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
West Coast Endoscopy Center
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Clinical Research of West Florida
mi
from
Clearwater, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Clinical Research of West Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Gastroenterology Group of Naples
mi
from
Naples, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Gastroenterology Group of Naples
mi
from
Naples, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Gulfshore Endoscopy Center (Endoscopies Only)
mi
from
Naples, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Gulfshore Endoscopy Center (Endoscopies Only)
mi
from
Naples, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
North Florida Gastroenterology Research, LLC
mi
from
Orange Park, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
North Florida Gastroenterology Research, LLC
mi
from
Orange Park, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Internal Medicine Specialists
mi
from
Orlando, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Internal Medicine Specialists
mi
from
Orlando, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Gastroenterology Associates of Central Georgia
mi
from
Macon, GA
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Gastroenterology Associates of Central Georgia
mi
from
Macon, GA
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
East Ann Arbor Health and Geriatrics Center
mi
from
Ann Arbor, MI
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
East Ann Arbor Health and Geriatrics Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
University of Michigan Health Systems
mi
from
Ann Arbor, MI
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
University of Michigan Health Systems
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Center for Digestive Health
mi
from
Troy, MI
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Center for Digestive Health
mi
from
Troy, MI
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Surgical Centers of Michigan
mi
from
Troy, MI
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Surgical Centers of Michigan
mi
from
Troy, MI
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Nyu Langone Long Island Clinical Research Associates
mi
from
Great Neck, NY
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Nyu Langone Long Island Clinical Research Associates
mi
from
Great Neck, NY
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
NYU Langone Nassau Gastroenterology Associates
mi
from
Great Neck, NY
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
NYU Langone Nassau Gastroenterology Associates
mi
from
Great Neck, NY
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Cleveland Clinic
mi
from
Cleveland, OH
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Great Lakes Gastroenterology
mi
from
Mentor, OH
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Great Lakes Gastroenterology
mi
from
Mentor, OH
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
The Endoscopy Center of Lake County
mi
from
Mentor, OH
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
The Endoscopy Center of Lake County
mi
from
Mentor, OH
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Great Lakes Gastroenterology
mi
from
Willoughby, OH
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Great Lakes Gastroenterology
mi
from
Willoughby, OH
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Digestive Health Specialists of Tyler
mi
from
Tyler, TX
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Digestive Health Specialists of Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Endoscopy Center of Tyler
mi
from
Tyler, TX
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Endoscopy Center of Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
University of Utah HSC
mi
from
Salt Lake City, UT
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
University of Utah HSC
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Wisconsin Center for Advanced Research - GI Associates, LLC
mi
from
Milwaukee, WI
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Wisconsin Center for Advanced Research - GI Associates, LLC
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Allegiance Research Specialists
mi
from
Wauwatosa, WI
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Allegiance Research Specialists
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
GI Associates
mi
from
Wauwatosa, WI
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
GI Associates
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Nepean Public Hospital
mi
from
Kingswood,
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Nepean Public Hospital
mi
from
Kingswood,
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Shands Endoscopy Center
mi
from
Gainesville, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Shands Endoscopy Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Shands Hospital at the University of Florida
mi
from
Gainesville, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Shands Hospital at the University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Investigational Drug Service
mi
from
Gainesville, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Investigational Drug Service
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Shands Medical Plaza and Cancer Center
mi
from
Gainesville, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Shands Medical Plaza and Cancer Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Digestive and Liver Disease Specialists
mi
from
Norfolk, VA
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Digestive and Liver Disease Specialists
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Christus Trinity Mother Frances Endoscopy Center
mi
from
Tyler, TX
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Christus Trinity Mother Frances Endoscopy Center
mi
from
Tyler, TX
Click here to add this to my saved trials
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated:  10/2/2017
North Little Rock
mi
from
North Little Rock, AR
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated: 10/2/2017
North Little Rock
mi
from
North Little Rock, AR
Click here to add this to my saved trials
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated:  10/2/2017
Manhattan
mi
from
New York, NY
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated: 10/2/2017
Manhattan
mi
from
New York, NY
Click here to add this to my saved trials
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated:  10/2/2017
Manhattan
mi
from
New York, NY
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated: 10/2/2017
Manhattan
mi
from
New York, NY
Click here to add this to my saved trials
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated:  10/2/2017
Manhattan
mi
from
New York, NY
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated: 10/2/2017
Manhattan
mi
from
New York, NY
Click here to add this to my saved trials
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated:  10/2/2017
Investigator Site - Cincinnati
mi
from
Cincinnati, OH
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated: 10/2/2017
Investigator Site - Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated:  10/2/2017
Hagerstown
mi
from
Hagerstown, MD
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Status: Enrolling
Updated: 10/2/2017
Hagerstown
mi
from
Hagerstown, MD
Click here to add this to my saved trials